Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial
PaperCitations, authors & open-access status
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 23 citations, 2023 year and hybrid oa status.
23
Citations
2023
Year
hybrid
OA Status